Skip to main content
Skip to footer
Home
About
About
Management
Board of Directors
Scientific-Medical
Advisory Board
Company Values
Pipeline
Pipeline
Vidofludimus Calcium
IMU-856
IMU-381
News
News Releases
Photo Corner
Video Corner
Publications
Investors
IR Home
News Releases
Events and Presentations
Stock Information
Financials and SEC Filings
Corporate Governance
IR Contact
Career
Contact
Home
About
About
Management
Board of Directors
Scientific-Medical
Advisory Board
Company Values
Pipeline
Pipeline
Vidofludimus Calcium
IMU-856
IMU-381
News
News Releases
Photo Corner
Video Corner
Publications
Investors
IR Home
News Releases
Events and Presentations
Stock Information
Financials and SEC Filings
Corporate Governance
IR Contact
Career
Contact
Main Phase 2 Analysis IMU-838 in Moderate COVID-19 & Phase 2 Proof-of-Concept Study IMU-838 in PSC
February 18, 2021
Presentation IMU-838 COVID-19 PSC Data 2021
Play Recording IMU-838 COVID-19 PSC Data 2021
Next Post
Clinical Relevance of Intestinal Barrier Dysfunction in Common Gastrointestinal Diseases
30th Annual Meeting of the Society for Virology
Home – 2
About
Pipeline
News
Publications
Investors
Career
Contact
Management
Board of Directors
Scientific-Medical
Advisory Board
Company Values
Vidofludimus Calcium
IMU-856
IMU-381
IR Home
News Releases
Events and Presentations
Stock Informations
Financials and SEC Filings
Corporate Governance
IR Contact
Search
Search
